Aker BioMarine signs with medical food firm, taking 'breakthrough' human health product a step closer to market

Launch of first medical food and dietary supplement is planned for 2024.

AkerBioMarine CEO Matts Johansen says "the collaboration with Trofi is an important milestone in commercializing Lysoveta."
AkerBioMarine CEO Matts Johansen says "the collaboration with Trofi is an important milestone in commercializing Lysoveta."IntraFish
Published 1 September 2022, 07:58Updated 1 September 2022, 13:39
Aker BiomarineMatts JohansenKrillUnited States